Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-09-26
2006-09-26
Mosher, Mary E. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C514S04400A
Reexamination Certificate
active
07112331
ABSTRACT:
The present invention relates to compositions for the treatment or prevention of Zoster of individuals infected with Varicella Zoster virus (VZV), and to the prevention and treatment of Varicella infections. The compositions of the invention comprise the protein encoded by VZV gene 63 or an immunologically active derivative thereof. The invention further relates to compositions containing DNA or RNA corresponding to VZV gene 63.
REFERENCES:
patent: 5306635 (1994-04-01), Keller et al.
patent: 0 244 155 (1987-11-01), None
patent: 0 405 867 (1991-01-01), None
patent: WO 94/00153 (1994-06-01), None
Nader et al. Journal of Enfectious Diseases 7:13-17, 1995.
Kinchington et al. Journal of Virology 69:4274-4282, 1995.
Debrus et al. Journal of Virology 69:3240-3245, May 1995.
Dunkel et al. Neurology 45 (suppl 8): S21-S22, 1995.
USP27 NF22. The United States Pharmacopeia, The National Formulary, 2004. United States Pharmacopeial Convention, Inc. , Rockville, MD. pp. 2628-2636, 1949-1951.
Liu et al (Clinical Biochemistry 30:455-463, 1997).
Wicks et al (Human Gene Therapy 6 (3): 317-323, abstract only cited).
Debrus et al., “Varicella-Zoster Virus Gene 63 Encodes an Immediate-Early Protein That is Abundantly Expressed during Latency”, Journal of Virology, May 1995, p. 3240-3245.
Phelan, et al., “A herpes simples virus type 1 immediate-early gene product, IE63, regulated small nuclear ribonucleoprotein distribution”,Proc. Natl. Acad. Sci. USA,90: 9056-9060 (1993).
Kennedy, et al., “Down-Regulation of Glial Fibrillary Acidic Protein Expression during Acute Lytic Varicella-Zoster Virus Infection of Cultured Human Astrocytes”,Virology,205: 558-562 (1994).
Paul R. Kinchington, et al., “The Transcriptional Regulatory Proteins Encoded by Varicella-Zoster Virus Open Reading Frames (ORF's) 4 and 63, but Not ORF 61, Are Associated with Purified Virus Particles,” Journal of Virology, Jul. 1995 vol. 69 p. 4274-4282.
Rentier Bernard
Sadzot Catherine
Cimmi Edward R.
Fedon Jason C.
Mosher Mary E.
Rinzig Charles M.
SmithKline Beecham Biologicals (s.a.)
LandOfFree
Vaccines against varicella zoster virus gene 63 product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines against varicella zoster virus gene 63 product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines against varicella zoster virus gene 63 product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3553616